These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 26807494)
1. Assessing disease activity in psoriasis and psoriatic arthritis: impact on management and therapy. Chandran V; Maharaj AB Expert Rev Clin Immunol; 2016; 12(5):573-82. PubMed ID: 26807494 [TBL] [Abstract][Full Text] [Related]
2. Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11. Coates LC; FitzGerald O; Mease PJ; Gladman DD; Strand V; Goel N; Campbell I; Krueger G; McHugh NJ; Helliwell PS J Rheumatol; 2014 Apr; 41(4):782-91. PubMed ID: 24488420 [TBL] [Abstract][Full Text] [Related]
3. A review of disease activity measures for psoriatic arthritis: what is the best approach? Her M; Kavanaugh A Expert Rev Clin Immunol; 2014 Sep; 10(9):1241-54. PubMed ID: 25088300 [TBL] [Abstract][Full Text] [Related]
4. Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Mease PJ; Boehncke WH; Gladman DD J Rheumatol; 2013 Aug; 40(8):1407-9. PubMed ID: 23908533 [TBL] [Abstract][Full Text] [Related]
5. Outcome measures for psoriasis severity: a report from the GRAPPA 2012 annual meeting. Callis Duffin K; Gottlieb AB J Rheumatol; 2013 Aug; 40(8):1423-4. PubMed ID: 23908537 [TBL] [Abstract][Full Text] [Related]
6. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Gossec L; de Wit M; Kiltz U; Braun J; Kalyoncu U; Scrivo R; Maccarone M; Carton L; Otsa K; Sooäär I; Heiberg T; Bertheussen H; Cañete JD; Sánchez Lombarte A; Balanescu A; Dinte A; de Vlam K; Smolen JS; Stamm T; Niedermayer D; Békés G; Veale D; Helliwell P; Parkinson A; Luger T; Kvien TK; Ann Rheum Dis; 2014 Jun; 73(6):1012-9. PubMed ID: 24790067 [TBL] [Abstract][Full Text] [Related]
7. Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies. Raychaudhuri SP; Wilken R; Sukhov AC; Raychaudhuri SK; Maverakis E J Autoimmun; 2017 Jan; 76():21-37. PubMed ID: 27836567 [TBL] [Abstract][Full Text] [Related]
9. Psoriasis and psoriatic arthritis treatment. Menter A Am J Manag Care; 2016 Jun; 22(8 Suppl):s225-37. PubMed ID: 27356194 [TBL] [Abstract][Full Text] [Related]
10. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Lebwohl MG; Kavanaugh A; Armstrong AW; Van Voorhees AS Am J Clin Dermatol; 2016 Feb; 17(1):87-97. PubMed ID: 26718712 [TBL] [Abstract][Full Text] [Related]
11. Psoriasis and Psoriatic Arthritis Video Project 2010: a report from the GRAPPA annual meeting. Callis Duffin K; Mease PJ J Rheumatol; 2011 Mar; 38(3):562-3. PubMed ID: 21362788 [TBL] [Abstract][Full Text] [Related]
12. ALIGN PsA: Advancing a Multidisciplinary Approach in PsA. Baum EW; Schwartzman S Semin Cutan Med Surg; 2018 Dec; 37(6S):S125-S134. PubMed ID: 30605493 [TBL] [Abstract][Full Text] [Related]
13. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Mease PJ Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S64-85. PubMed ID: 22588772 [No Abstract] [Full Text] [Related]
14. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014. Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828 [TBL] [Abstract][Full Text] [Related]
15. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative. Perez-Chada LM; Cohen JM; Gottlieb AB; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF Arch Dermatol Res; 2018 Nov; 310(9):701-710. PubMed ID: 30167814 [TBL] [Abstract][Full Text] [Related]
17. Pediatric psoriasis and psoriatic arthritis. Lewkowicz D; Gottlieb AB Dermatol Ther; 2004; 17(5):364-75. PubMed ID: 15379771 [TBL] [Abstract][Full Text] [Related]
18. Report of the Skin Research Working Groups from the GRAPPA 2017 Annual Meeting. Gottlieb AB; Coates LC; van Mens LJJ; Armstrong AW; Merola JF J Rheumatol Suppl; 2018 Jun; 94():40-43. PubMed ID: 29858353 [TBL] [Abstract][Full Text] [Related]
19. Immunologic advances reveal new targets in psoriasis and psoriatic arthritis. Mortezavi M; Ritchlin C Discov Med; 2015 Oct; 20(110):169-75. PubMed ID: 26562469 [TBL] [Abstract][Full Text] [Related]
20. Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative. Perez-Chada LM; Salame NF; Ford AR; Duffin KC; Garg A; Gottlieb AB; Latella J; Merola JF; Armstrong AW Am J Clin Dermatol; 2020 Jun; 21(3):323-338. PubMed ID: 31950353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]